Thrombus Is Resistant To Fibrinolysis In Patients With Chronic Thromboembolic Pulmonary Hypertension -Possible Involvement Of Thrombin Activated Fibrinolysis Inhibitor (tafi)-

被引：0
|
作者：
Yaoita, N. [1 ]
Fukumoto, Y. [1 ]
Horiuchi, H. [2 ]
Shimokawa, H. [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan
[2] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3338
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Resistance of Thrombus to Fibrinolysis in Patients With Chronic Thromboembolic Pulmonary Hypertension -Possible Involvement of Thrombin-Activated Fibrinolysis Inhibitor (TAFI)
    Yaoita, Nobuhiro
    Fukumoto, Yoshihiro
    Kawamura, Takeshi
    Horiuchi, Hisanori
    Shimokawa, Hiroaki
    CIRCULATION, 2013, 128 (22)
  • [2] Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension
    Yaoita, Nobuhiro
    Satoh, Kimio
    Satoh, Taijyu
    Sugimura, Koichiro
    Tatebe, Shunsuke
    Yamamoto, Saori
    Aoki, Tatsuo
    Miura, Masanobu
    Miyata, Satoshi
    Kawamura, Takeshi
    Horiuchi, Hisanori
    Fukumoto, Yoshihiro
    Shimokawa, Hiroaki
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (06) : 1293 - +
  • [3] Crucial role of thrombin-activated fibrinolysis inhibitor in the pathogenesis of chronic thromboembolic pulmonary hypertension
    Yaoita, Nobuhiro
    Satoh, Taijyu
    Satoh, Kimio
    Sugimura, Koichiro
    Tatebe, Shunsuke
    Aoki, Tatsuo
    Miura, Masanobu
    Fukumoto, Yoshihiro
    Horiuchi, Hisanori
    Shimokawa, Hiroaki
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [4] Thrombin activatable fibrinolysis inhibitor (TAFI) and fibrinolysis in patients with diabetic nephropathy
    Stasko, J
    Galajda, P
    Holman, B
    Sutarík, L
    Kubisz, P
    PROCEEDINGS OF THE XVII MEETING INTERNATIONAL SOCIETY OF HAEMATOLOGY (EUROPEAN AND AFRICAN DIVISION), 2003, : 193 - 197
  • [5] Thrombin Activatable Fibrinolysis Inhibitor Promotes Development of Chronic Thromboembolic Pulmonary Hypertension -A Possible Novel Therapeutic Target
    Satoh, Taijyu
    Satoh, Kimio
    Yaoita, Nobuhiro
    Kikuchi, Nobuhiro
    Omura, Junichi
    Kurosawa, Ryo
    Sunamura, Shinichiro
    Nogi, Masamichi
    Otsuki, Tomohiro
    Numano, Kazuhiko
    Al-Mamun, Md Elias
    Siddique, Mohammad Abdul Hai
    Tatebe, Shunsuke
    Aoki, Tatsuo
    Sugimura, Koichiro
    Morser, John
    Shimokawa, Hiroaki
    CIRCULATION, 2016, 134
  • [6] Resistance to Fibrinolysis in Patients with Chronic Thromboembolic Pulmonary Hypertension
    Yaoita, Nobuhiro
    Fukumoto, Yoshihiro
    Shimokawa, Hiroaki
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S187 - S188
  • [7] Thrombin activatable fibrinolysis inhibitor promotes development of chronic thromboembolic pulmonary hypertension -A possible novel therapeutic target-
    Satoh, T.
    Satoh, K.
    Yaoita, N.
    Al-Mamun, M. E.
    Siddique, M. A. H.
    Kikuchi, N.
    Omura, J.
    Kurosawa, R.
    Sunamura, S.
    Nogi, M.
    Otsuki, T.
    Miyata, S.
    Shimokawa, H.
    EUROPEAN HEART JOURNAL, 2017, 38 : 411 - 412
  • [8] Role of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with acute pulmonary embolism
    Schroeder, V
    Kucher, N
    Kohler, HP
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (03) : 492 - 493
  • [9] Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease
    Van Thiel, DH
    George, M
    Fareed, J
    THROMBOSIS AND HAEMOSTASIS, 2001, 85 (04) : 667 - 670
  • [10] Design of peptide-based inhibitors of Thrombin Activated Fibrinolysis Inhibitor (TAFI).
    Beight, DW
    Do, YH
    Gifford-Moore, D
    Harper, RW
    Klimkowski, VJ
    Lu, DS
    Ma, TW
    Rathnachalam, R
    Smiley, DL
    Smith, SM
    Warshawsky, A
    Wiley, MR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U16 - U16
12345